Sabiad

Sabiad offers integrated diagnostic and therapeutic solutions for precise bacterial infection management.

Based based in Silicon Valley, California, Sabiad works in health & longevity.

Profile

Sabiad is a biotechnology company specializing in precision theranostics for bacterial infections, with a focus on Staphylococcus aureus. The company integrates diagnostic and therapeutic processes through its patented StaphMark platform, which employs the 1D9 antibody to accurately detect, visualize, and deliver targeted treatment for infections in real time. This technology is applicable in operating rooms and at point-of-care, addressing critical challenges in surgical infection management. By enhancing diagnostic accuracy and personalizing treatment, Sabiad aims to reduce antibiotic overuse, minimize complications, and combat antimicrobial resistance. The company’s innovative approach supports healthcare professionals in improving patient recovery and advancing healthcare efficiency.

Sabiad is positioned in health & longevity, a segment that rewards a clear, focused offering.

The company is recorded as being based in Silicon Valley, California.

It is recorded at the Plug and Play accelerated startup stage.

Website: www.sabiad.eu